272 related articles for article (PubMed ID: 15710212)
1. New insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNA.
Zoulim F
J Hepatol; 2005 Mar; 42(3):302-8. PubMed ID: 15710212
[No Abstract] [Full Text] [Related]
2. Quantitative analysis of HBV cccDNA from clinical specimens: correlation with clinical and virological response during antiviral therapy.
Bourne EJ; Dienstag JL; Lopez VA; Sander TJ; Longlet JM; Hall JG; Kwiatkowski RW; Wright T; Lai CL; Condreay LD
J Viral Hepat; 2007 Jan; 14(1):55-63. PubMed ID: 17212645
[TBL] [Abstract][Full Text] [Related]
3. CccDNA persistence during natural evolution of chronic VHB infection.
Caruntu FA; Molagic V
Rom J Gastroenterol; 2005 Dec; 14(4):373-7. PubMed ID: 16400354
[TBL] [Abstract][Full Text] [Related]
4. One-year entecavir or lamivudine therapy results in reduction of hepatitis B virus intrahepatic covalently closed circular DNA levels.
Wong DK; Yuen MF; Ngai VW; Fung J; Lai CL
Antivir Ther; 2006; 11(7):909-16. PubMed ID: 17302253
[TBL] [Abstract][Full Text] [Related]
5. Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients.
Laras A; Koskinas J; Dimou E; Kostamena A; Hadziyannis SJ
Hepatology; 2006 Sep; 44(3):694-702. PubMed ID: 16941694
[TBL] [Abstract][Full Text] [Related]
6. [Quantitative analysis of HBV cccDNA from liver biopsy specimens in HBV carriers: correlation with serological makers and sera HBV DNA].
Zhang L; Wu F; Shi LL; Dou XG
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Apr; 25(2):112-3. PubMed ID: 21863632
[TBL] [Abstract][Full Text] [Related]
7. Quantification of hepatitis B virus covalently closed circular DNA in patients with hepatocellular carcinoma.
Wong DK; Yuen MF; Poon RT; Yuen JC; Fung J; Lai CL
J Hepatol; 2006 Oct; 45(4):553-9. PubMed ID: 16904225
[TBL] [Abstract][Full Text] [Related]
8. Evidence that methylation of hepatitis B virus covalently closed circular DNA in liver tissues of patients with chronic hepatitis B modulates HBV replication.
Guo Y; Li Y; Mu S; Zhang J; Yan Z
J Med Virol; 2009 Jul; 81(7):1177-83. PubMed ID: 19475606
[TBL] [Abstract][Full Text] [Related]
9. Validation of a sensitive and specific real-time PCR for detection and quantitation of hepatitis B virus covalently closed circular DNA in plasma of chronic hepatitis B patients.
Takkenberg RB; Zaaijer HL; Molenkamp R; Menting S; Terpstra V; Weegink CJ; Dijkgraaf MG; Jansen PL; Reesink HW; Beld MG
J Med Virol; 2009 Jun; 81(6):988-95. PubMed ID: 19382261
[TBL] [Abstract][Full Text] [Related]
10. Correlation between serum hepatitis B virus core-related antigen and intrahepatic covalently closed circular DNA in chronic hepatitis B patients.
Suzuki F; Miyakoshi H; Kobayashi M; Kumada H
J Med Virol; 2009 Jan; 81(1):27-33. PubMed ID: 19031469
[TBL] [Abstract][Full Text] [Related]
11. [Establishment and application of a real-time PCR method to detect hepatitis B virus cccDNA quantitatively].
Zhuang LW; Lu HY; Yu YY; Si CW; Yu M; Zhang NL; Gong WB
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):182-4. PubMed ID: 17653331
[TBL] [Abstract][Full Text] [Related]
12. Serum hepatitis B core-related antigen is a satisfactory surrogate marker of intrahepatic covalently closed circular DNA in chronic hepatitis B.
Chen EQ; Feng S; Wang ML; Liang LB; Zhou LY; Du LY; Yan LB; Tao CM; Tang H
Sci Rep; 2017 Mar; 7(1):173. PubMed ID: 28282964
[TBL] [Abstract][Full Text] [Related]
13. Intracellular levels of hepatitis B virus DNA and pregenomic RNA in peripheral blood mononuclear cells of chronically infected patients.
Lu L; Zhang HY; Yueng YH; Cheung KF; Luk JM; Wang FS; Lau GK
J Viral Hepat; 2009 Feb; 16(2):104-12. PubMed ID: 19175882
[TBL] [Abstract][Full Text] [Related]
14. Control of cccDNA function in hepatitis B virus infection.
Levrero M; Pollicino T; Petersen J; Belloni L; Raimondo G; Dandri M
J Hepatol; 2009 Sep; 51(3):581-92. PubMed ID: 19616338
[TBL] [Abstract][Full Text] [Related]
15. [On the detection of HBV cccDNA and its clinical significance: an overview of research advancement].
Li H; Tang H
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Jun; 26(3):662-6. PubMed ID: 19634693
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of antiviral treatment on intrahepatic HBV DNA and histology in HBeAg -positive chronic hepatitis B patients].
Lu HY; Zhuang LW; Yu YY; Si CW; Zheng JJ; Chen XY; Han ZH; Chen Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Feb; 22(1):54-6. PubMed ID: 18414702
[TBL] [Abstract][Full Text] [Related]
17. Viral covalently closed circular DNA in a non-transgenic mouse model for chronic hepatitis B virus replication.
Takehara T; Suzuki T; Ohkawa K; Hosui A; Jinushi M; Miyagi T; Tatsumi T; Kanazawa Y; Hayashi N
J Hepatol; 2006 Feb; 44(2):267-74. PubMed ID: 16226822
[TBL] [Abstract][Full Text] [Related]
18. Can serum HBV-DNA be used as a primary end point to assess efficacy of new treatments for chronic hepatitis B?
Alberti A
Hepatology; 2003 Jul; 38(1):18-20. PubMed ID: 12829981
[No Abstract] [Full Text] [Related]
19. [Quantitative detection of hepatitis B virus covalently closed circular DNA in sera of chronic hepatitis B patients with a newly established assay].
Zhong YW; Liang ZL; Ren XQ; Li XD; Xu ZH; Li L; Xu DP
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Jun; 22(3):225-7. PubMed ID: 19031711
[TBL] [Abstract][Full Text] [Related]
20. Sequential combination therapy for chronic hepatitis B: more challenges to be tackled.
Tseng TC; Liu CJ; Kao JH
Am J Gastroenterol; 2007 Jul; 102(7):1544; author reply 1545. PubMed ID: 17593169
[No Abstract] [Full Text] [Related]
[Next] [New Search]
